Filing metadata

Accession number
0001609351-16-000012
Form type
Form 3
Filer
Spark Therapeutics, Inc.
CIK
CIK 1609351
Filed
Jan 08, 2016
Reporting period
Jan 06, 2016
Description
Initial ownership

Explore SEC Filings Hub